Protein Binding Comparison of Loop Diuretics
All three loop diuretics are highly protein bound (>90%), but bumetanide exhibits the highest degree of protein binding at 94-96%, followed by torsemide at >99%, and furosemide at 91-99% depending on plasma concentration.
Specific Protein Binding Data
Furosemide
- Protein binding: 91-99% at therapeutic concentrations (1-400 µg/mL), with unbound fraction averaging 2.3-4.1% 1
- Extensively bound to plasma proteins, mainly albumin 1
- In analbuminemic rats, protein binding dropped to only 12% (primarily globulin binding) 2, 3
Torsemide
- Protein binding: >99% 4
- Extensively bound to plasma protein 4
- In analbuminemic rats, protein binding was 23.3% (binding to α- and β-globulins), which was notably higher than furosemide's 12% in the same model 2
Bumetanide
- Protein binding: 94-96% 5
- In analbuminemic rats, protein binding was 36.8% (mainly α- and β-globulins), substantially higher than furosemide's 12% 3
- Studies confirm bumetanide is highly protein bound at 96.7% in normal conditions 6
Clinical Implications of Protein Binding
The degree of protein binding directly impacts renal tubular delivery and diuretic efficacy. Because loop diuretics must be secreted into the proximal tubule to reach their site of action in the loop of Henle, only the unbound fraction can undergo glomerular filtration and active tubular secretion 4, 1, 5.
Key Clinical Points:
Bumetanide's higher protein binding (compared to furosemide in disease states) may provide more stable drug delivery, though this translates to similar clinical efficacy 7
In hypoalbuminemic states (liver disease, nephrotic syndrome), all three agents will have increased free fractions, potentially leading to:
- Enhanced diuretic effect initially
- Faster clearance
- Need for dose adjustments 8
Torsemide's very high protein binding (>99%) does not confer clinical advantages over furosemide despite theoretical benefits; the TRANSFORM-HF trial showed no mortality difference 9, 10
Practical Considerations
The extensive protein binding of all three agents means:
- Drug interactions with other highly protein-bound medications are possible
- Albumin levels should be considered when dosing, particularly in critically ill patients
- Renal clearance is primarily via active tubular secretion rather than glomerular filtration 4, 1, 5
In neonates with hyperbilirubinemia, bumetanide displaces significantly less bilirubin from albumin at therapeutic concentrations than furosemide, making it potentially safer in this population 6.